Exclusion Criteria:~* History or evidence of, active malignancy, except for basal cell carcinoma or squamous
cell carcinoma of the skin, within the 24 months prior to entry. Men with prostate cancer may be enrolled at
the discretion of the sponsor.~* Chronic or acute renal, hepatic or metabolic disorder.~* Use of any
investigational therapy within 30 days, or 5 half-lives, whichever is longer, and/or use of AD immunotherapy
prior to screening.
